tiprankstipranks
Advertisement
Advertisement

AU:RNV Stock Latest News

Renerve Options Lapse Without Exercise, Trimming Potential Dilution
Company AnnouncementsRenerve Options Lapse Without Exercise, Trimming Potential Dilution
18d ago
RNV
ReNerve Clarifies Key Terms of Hong Kong Distribution Deal With STC
PremiumCompany Announcements
ReNerve Clarifies Key Terms of Hong Kong Distribution Deal With STC
18d ago
RNV
ReNerve Taps UG Medical to Drive NervAlign Rollout in Malaysia
PremiumCompany Announcements
ReNerve Taps UG Medical to Drive NervAlign Rollout in Malaysia
29d ago
RNV
ReNerve flags speculative risk as it prepares share offer
PremiumCompany Announcements
ReNerve flags speculative risk as it prepares share offer
2M ago
RNV
ReNerve to Brief Investors on Quarterly Results as Nerve Repair Device Gains Traction
PremiumCompany Announcements
ReNerve to Brief Investors on Quarterly Results as Nerve Repair Device Gains Traction
2M ago
RNV
ReNerve Accelerates Sales Growth and Advances Nerve Repair Pipeline
PremiumCompany AnnouncementsReNerve Accelerates Sales Growth and Advances Nerve Repair Pipeline
2M ago
RNV
ReNerve Advances NervAlign Nerve Guide Matrix Toward FDA Submission
Premium
Company Announcements
ReNerve Advances NervAlign Nerve Guide Matrix Toward FDA Submission
3M ago
RNV
Renerve trims option overhang with cancellation of long-dated securities
Premium
Company Announcements
Renerve trims option overhang with cancellation of long-dated securities
3M ago
RNV
ReNerve Issues New Shares Under Compliance Notice to ASX
PremiumCompany Announcements
ReNerve Issues New Shares Under Compliance Notice to ASX
3M ago
RNV
Renerve Seeks ASX Quotation for Additional Ordinary Shares
PremiumCompany Announcements
Renerve Seeks ASX Quotation for Additional Ordinary Shares
3M ago
RNV
Renerve Plans Equity Placement of Over 1 Million New Shares
PremiumCompany Announcements
Renerve Plans Equity Placement of Over 1 Million New Shares
3M ago
RNV
ReNerve Highlights Speculative Nature of Nerve Repair Investment in Investor Update
PremiumCompany Announcements
ReNerve Highlights Speculative Nature of Nerve Repair Investment in Investor Update
4M ago
RNV
ReNerve Sets Investor Webinar as Nerve Repair Portfolio Gains Clinical Traction
PremiumCompany AnnouncementsReNerve Sets Investor Webinar as Nerve Repair Portfolio Gains Clinical Traction
4M ago
RNV
ReNerve boosts nerve repair sales, expands U.S. and Asian market reach
Premium
Company Announcements
ReNerve boosts nerve repair sales, expands U.S. and Asian market reach
4M ago
RNV
ReNerve Widens Half-Year Loss as Net Tangible Assets Decline
Premium
Company Announcements
ReNerve Widens Half-Year Loss as Net Tangible Assets Decline
4M ago
RNV
ReNerve Lifts Quarterly Sales 80% as US Adoption Grows and Product Portfolio Expands
PremiumCompany Announcements
ReNerve Lifts Quarterly Sales 80% as US Adoption Grows and Product Portfolio Expands
5M ago
RNV
ReNerve Wins Malaysian Approval for NervAlign Nerve Cuff, Advancing Asia-Pacific Growth Plan
PremiumCompany Announcements
ReNerve Wins Malaysian Approval for NervAlign Nerve Cuff, Advancing Asia-Pacific Growth Plan
6M ago
RNV
Renerve Issues Over 30 Million New Unquoted Options
PremiumCompany Announcements
Renerve Issues Over 30 Million New Unquoted Options
6M ago
RNV
ReNerve Issues Over 5 Million New Shares Under Compliance Notice
PremiumCompany Announcements
ReNerve Issues Over 5 Million New Shares Under Compliance Notice
6M ago
RNV
Renerve Seeks ASX Quotation for 5.1 Million New Shares
PremiumCompany AnnouncementsRenerve Seeks ASX Quotation for 5.1 Million New Shares
6M ago
RNV
ReNerve Wins Expanded Hong Kong Approval for Flagship NervAlign Nerve Cuff
Premium
Company Announcements
ReNerve Wins Expanded Hong Kong Approval for Flagship NervAlign Nerve Cuff
6M ago
RNV
ReNerve Shareholders Back All Resolutions at 2026 General Meeting
Premium
Company Announcements
ReNerve Shareholders Back All Resolutions at 2026 General Meeting
6M ago
RNV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >